ESMO Clinical Practice Guidelines: Haematological Malignancies
Latest enhanced and revised set of guidelines
ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Acute lymphoblastic leukaemia, Acute myeloblastic leukaemia in adult patients, Chronic lymphocytic leukaemia, Chronic myeloid leukaemia, Diffuse large B cell lymphoma, Elderly patients with malignant lymphoma, Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma, Follicular Lymphoma, Hairy cell leukaemia, Hodgkin lymphoma, Human immunodeficiency virus-associated lymphomas, Management of ultra-high-risk patients, Mantle cell lymphoma, Marginal zone lymphomas, Multiple myeloma, Myelodysplastic syndromes, Peripheral T-cell lymphomas, Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Primary central nervous system lymphomas, Primary cutaneous lymphoma, Prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia and Waldenstrom's macroglobulinaemia.
They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.